Sequent Scientific Ltd share price logo

Sequent Share Price

NSE: SEQUENT

BSE: 512529

Small Cap

Healthcare Sector

₹198.59

+7.39

(+3.87%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Sequent Stock Performance

as on September 18, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹189.98
    ₹200
    downward going graph

    4.34%

    Downside

    0.71%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹117.35
    ₹240.7
    downward going graph

    40.91%

    Downside

    21.20%

    Upside

    downward going graph

Sequent share price movements today

Previous Close
₹191.20
Open
₹192.40
Volume
24.69L
Upper Circuit
₹229.44
Lower Circuit
₹152.96
Day's Low - High
₹189.98 - ₹200
52 Week Low - High
₹117.35 - ₹240.7

Sequent Historical Returns

1 Month Return
+ 8.86 %
3 Month Return
-1.42 %
1 Year Return
+ 7.51 %
3 Year Return
+ 76.79 %
5 Year Return
+ 26.41 %

Sequent Fundamentals

as on September 18, 2025 at 4:01 pm IST

Market Cap

₹4,811.60 Cr

Return on Equity (ROE)

1.42

PE Ratio (TTM)

160.67

Return on capital employed (ROCE)

2.23

Industry PE ratio

42.21

Beta (LTM)

1.54

P/B Ratio

2.87

Dividend Yield

0

PEG Ratio

163.95

Quarterly Earnings Growth YOY

93.93

EPS (TTM)

1.29

Sector

Pharmaceuticals

Book Value

28.15

Technical Analysis

Bullish

View Technical Analysis

Sequent Stock Valuation

as on September 18, 2025 at 4:01 pm IST

Sequent in the last 5 years

  • Overview

  • Trends

Lowest (-117.80x)

January 17, 2023

Industry (42.21x)

September 17, 2025

Today (160.67x)

September 17, 2025

Highest (1034.67x)

September 27, 2024

LowHigh

Today’s Price to Earnings Ratio: 160.67x

Sequent Scientific Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sequent with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Sequent Scientific Ltd image
Sequent Scientific Ltd
NA4,811.605.28%0.72321,551
Medico Remedies Ltd image
Medico Remedies Ltd
NA323.0612.17%0.0010150
Alivus Life Sciences Ltd image
Alivus Life Sciences Ltd
BUY11,519.785.09%0.004852,386
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA1,315.392290.77%0.00932
NGL Fine Chem Ltd image
NGL Fine Chem Ltd
NA836.28-5.52%0.6121368
See all

Sequent Stock's Interest Amongst Investors

Search interest for Sequent Scientific Ltd Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:52% versus previous 30 day period

Sequent Scientific Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
337.61
375.31
366.67
333.21
345.97
329.36
361.2
390.21
368.65
390.81
401.7
441.42
Other Income
0.91
2.86
1.74
0.79
9.72
7.28
4
2.68
4.51
5.84
1.66
3.87
Total Income
338.52
378.18
368.41
334
355.68
336.64
365.2
392.89
373.16
396.65
403.36
445.29
Expenses
334.74
364.98
431.63
364.96
330.84
307.11
333.64
348.26
333.87
356.62
355.8
390.48
Operating Profit
2.87
10.33
-64.96
-31.75
15.13
22.25
27.56
41.95
34.78
34.19
45.9
50.94
Operating Profit Margin %
0.85%
2.75%
-17.72%
-9.53%
4.37%
6.76%
7.63%
10.75%
9.43%
8.75%
11.43%
11.54%
Profit Before Interest, Tax and Depreciation
3.78
13.2
-63.23
-30.96
24.85
29.53
31.56
44.63
39.29
40.03
47.56
54.81
Interest
8.12
9.73
10.87
10.48
12.58
12.58
12.44
16.38
14.29
14.95
15.13
14.16
Depreciation
13.38
13.67
14.71
14.24
15.36
15.46
16.48
16.25
17.1
16.98
16.12
15.13
Profit Before Tax
-17.72
-10.2
-88.81
-55.68
-3.09
1.49
2.64
12
7.9
8.1
16.31
25.52
Tax Paid
-13.28
-0.42
3.64
-21
3.79
-9.19
1.37
2.94
1.56
1.62
5.93
7.95
Profit After Tax
-4.44
-9.78
-92.44
-34.68
-6.88
10.68
1.27
9.06
6.34
6.48
10.38
17.57
Total Net profit including share of profit / Loss from associate company
-4.44
-9.78
-92.44
-34.68
-6.88
10.68
1.27
9.06
6.34
6.48
10.38
17.57
EPS
-0.15
-0.36
-3.77
-1.4
-0.34
0.33
-0.04
0.26
0.11
0.14
0.37
0.57
Actual EPS
-0.15
-0.36
-3.77
-1.4
-0.34
0.33
-0.04
0.26
0.11
0.14
0.37
0.57
Adjusted EPS
-0.15
-0.36
-3.77
-1.4
-0.34
0.33
-0.04
0.26
0.11
0.14
0.37
0.57
Diluted EPS
-0.15
-0.36
-3.77
-1.4
-0.34
0.33
-0.04
0.26
0.1
0.13
0.36
0.56

Sequent Scientific Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
683.57
847.84
1,039.31
1,179.24
1,361.62
1,412.82
1,420.91
1,369.73
1,551.37
Other Income
11.08
446.54
8.67
10.09
8.36
10.85
6.39
10.96
14.69
Total Income
694.65
1,294.37
1,047.98
1,189.33
1,369.98
1,423.66
1,427.3
1,380.69
1,566.06
Expenses
643.15
775.67
914.37
1,008.92
1,158.37
1,303.42
1,473.75
1,325.71
1,394.55
Operating Profit
40.42
72.17
124.94
170.32
203.25
109.4
-52.84
44.02
156.82
Operating Profit Margin %
5.91%
8.51%
12.02%
14.44%
14.93%
7.74%
-3.72%
3.21%
10.11%
Profit Before Interest, Tax and Depreciation
51.5
518.7
133.61
180.41
211.61
120.25
-46.45
54.98
171.51
Interest
28.34
33.07
32.8
35.71
24.38
15.77
35.52
48.09
60.75
Depreciation
40.07
41.34
41.92
50.62
50.6
51.54
55.69
61.54
66.45
Profit Before Tax
-16.91
444.29
58.89
94.08
136.63
52.94
-137.66
-54.65
44.31
Tax Paid
-0.53
13.46
2
12.03
32.18
8.17
-15.68
-25.03
12.05
Profit After Tax
-16.39
430.83
56.88
82.05
104.45
44.76
-121.98
-29.62
32.26
Total Net profit including share of profit / Loss from associate company
-16.39
430.83
56.88
82.05
104.45
44.76
-121.98
-29.62
32.26
EPS
-0.57
-0.11
2
2.87
3.87
1.65
-4.88
-1.44
0.88
Actual EPS
-0.57
-0.11
2
2.87
3.87
1.65
-4.88
-1.44
0.88
Adjusted EPS
-0.53
-0.1
2
2.87
3.87
1.65
-4.88
-1.44
0.88
Diluted EPS
-0.57
-0.11
1.99
2.85
3.85
1.63
-4.88
-1.44
0.85

Sequent Scientific Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-0.05
-7.19
45.24
116.02
115.33
114.75
30.6
16.81
30.6
83.36
Cash Flow from Investing Activities
-244.92
-37.44
54.18
-67.7
-72.27
9.64
-94.09
-64.96
-5.93
-24.78
Cash Flow from Financing Activities
308.69
147.44
-56.97
-20.1
-42.75
-138.76
67.25
32.22
-1.45
-60.73
Net Cash Flow
-1.82
24.07
-4.55
28.25
0.31
-14.35
3.75
-15.92
23.24
-2.15

Sequent Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
52.79%
52.79%
52.79%
52.79%
52.79%
52.79%
52.78%
52.76%
52.61%
52.61%
52.61%
DII
2.81%
2.92%
2.92%
3.23%
5.02%
7.59%
8.06%
9.99%
12.02%
12.82%
12.98%
FII
0%
0%
0%
6.03%
0%
6.16%
5.7%
6.45%
6.1%
6.05%
6.15%
Public
37.76%
38.01%
37.64%
37.57%
33.7%
33.29%
33.3%
30.63%
29.11%
28.36%
28.1%
Total Outstanding Shares
24,94,33,495
24,94,33,495
24,94,33,495
24,94,33,495
24,94,33,495
24,94,33,495
24,94,80,995
24,95,81,995
25,03,01,995
25,03,01,995
25,03,04,995
Total Shareholders
1,96,231
1,91,875
1,87,474
1,84,521
1,72,853
1,66,593
1,63,693
1,54,603
1,62,574
1,58,152
1,47,320

Mutual Funds that own Sequent Stock

Check out the Mutual Funds with significant holdings in Sequent.

Sequent Earnings and Dividends

View detailed summary of the earnings and dividend history of Sequent.

  • Sequent Scientific Ltd Earnings Results

    Sequent Scientific Ltd’s net profit jumped 119.82% since last year same period to ₹14.31Cr in the Q1 2025-2026. On a quarterly growth basis, Sequent Scientific Ltd has generated 53.54% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Sequent Scientific Ltd Dividends June,2021

    In the quarter ending March 2021, Sequent Scientific Ltd has declared dividend of ₹0.50 per share on 30 Jun 2021 - translating a dividend yield of 0.26%.

    Read More about Dividends

Indices Featuring Sequent Stock

Check stock indices that include Sequent.

BSE Healthcare

₹45,130.04

0.87 (▲391.31%)

BSE Small-Cap

₹54,532.75

-0.01 (▲-4.28%)

Insights on Sequent Scientific Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 2.61 Cr → 14.31 Cr (in ₹), with an average increase of 40.7% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 6.05% to 6.15% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 373.16 Cr → 445.29 Cr (in ₹), with an average increase of 5.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SEQUENT stock has moved up by 4.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 52.61% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 10.7% return, outperforming this stock by 3.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.7% return, outperforming this stock by 62.9%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 28.36% to 28.10% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 10.22% to 10.08% in Jun 2025 quarter

About Sequent Scientific Ltd

Visistha Traders Finance Ltd has combined itself with PI Drugs and Pharmaceuticals Ltd. Confirmation of amalgamation was approved by the High Court on November 12th 2003. As a result, one of the leading companies in the Indian pharmaceutical industry is now under its wing. It is anticipated that the move will benefit both the companies, shareholders and society at large. It will help Visistha Traders further solidify its creative and enterprising portfolio while aiding PI Drugs expand its reach and customer base. The amalgamation will make it easier to access the required resources, human and capital in a more efficient manner. Another positive factor of this step is that it will reduce administrative costs, allowing for a more productive use of resources. Combining the skill sets of both firms also ensures the sector benefits the most efficient and cutting-edge solutions. All in all, this is a step that is expected to lead to a brighter future for the pharmaceutical sector.

Revenue: ₹441.42Cr as on June 2025 (Q1 FY26)
Net Profit: ₹17.57Cr as on June 2025 (Q1 FY26)
Listing date: 10 Mar, 2016
Chairperson Name: Kamal K Sharma
OrganisationSequent Scientific Ltd
HeadquartersBangalore
IndustryPharmaceuticals
CEOKamal K Sharma
E-voting on sharesClick here to vote

FAQs

What is Sequent share price today?

Sequent share price today stands at ₹198.59 as on at the close of the market. Sequent share today touched a day high of ₹200 and a low of ₹189.98.

What is the 52 week high and 52 week low range for Sequent share?

Sequent touched a 52 week high of ₹240.7 and a 52 week low of ₹117.35. Sequent share price today i.e. is closed at ₹198.59, which is -17.49% down from its 52 week high and 69.23% up from its 52 week low.

What is Sequent's market capitalisation today?

Sequent market capitalisation is ₹4,811.60 Cr as on .

How to buy Sequent shares?

To buy Sequent shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SEQUENT or Sequent Scientific Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sequent shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sequent trading volume today?

Sequent trading volume is 24.69L as on . This means that 24.69L shares of Sequent were bought and sold on the stock market during today's trading session.